United States Active Pharmaceutical Ingredient Market Report 2018

January 2018 | 124 pages | ID: U6F568B576FEN
QYResearch

Abstracts

In this report, the United States Active Pharmaceutical Ingredient market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Active Pharmaceutical Ingredient in these regions, from 2013 to 2025 (forecast).

United States Active Pharmaceutical Ingredient market competition by top manufacturers/players, with Active Pharmaceutical Ingredient sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Teva
• Novartis
• Pfizer
• Johnson & Johnson
• Mylan
• North China Pharmaceutical Group
• Dr. Reddy’s Laboratories
• Roche
• Aurobindo pharma
• Sun Pharmaceutical Industries
• Boehringer Ingelheim GmbH
• Bayer
• BASF
• DSM
• Zhejiang Medicine
• Biocon
• Johnson Matthey
• Hisun Pharmacy
• Cambrex
• Shandong Xinhua Pharmaceutical
• Lonza group
• Huahai Pharmaceutical
• Haerbin Pharmaceutical Group
• Cipla
• Tian Yao
• Lupin
• North East Pharmaceutical
• Albemarle
• Shandong Lukang Pharmaceutical
• Jiangsu　Hengrui Medicine

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Synthetic API
• Biotech API
• Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Chemical
• Deodorant
• Dailylife

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Active Pharmaceutical Ingredient Market Report 2018

1 ACTIVE PHARMACEUTICAL INGREDIENT OVERVIEW

1.1 Product Overview and Scope of Active Pharmaceutical Ingredient
1.2 Classification of Active Pharmaceutical Ingredient by Product Category
  1.2.1 United States Active Pharmaceutical Ingredient Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Active Pharmaceutical Ingredient Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 Synthetic API
  1.2.4 Biotech API
  1.2.5 Other
1.3 United States Active Pharmaceutical Ingredient Market by Application/End Users
  1.3.1 United States Active Pharmaceutical Ingredient Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Chemical
  1.3.3 Deodorant
  1.3.4 Dailylife
1.4 United States Active Pharmaceutical Ingredient Market by Region
  1.4.1 United States Active Pharmaceutical Ingredient Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Active Pharmaceutical Ingredient Status and Prospect (2013-2025)
  1.4.3 Southwest Active Pharmaceutical Ingredient Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Active Pharmaceutical Ingredient Status and Prospect (2013-2025)
  1.4.5 New England Active Pharmaceutical Ingredient Status and Prospect (2013-2025)
  1.4.6 The South Active Pharmaceutical Ingredient Status and Prospect (2013-2025)
  1.4.7 The Midwest Active Pharmaceutical Ingredient Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Active Pharmaceutical Ingredient (2013-2025)
  1.5.1 United States Active Pharmaceutical Ingredient Sales and Growth Rate (2013-2025)
  1.5.2 United States Active Pharmaceutical Ingredient Revenue and Growth Rate (2013-2025)

2 UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENT MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Active Pharmaceutical Ingredient Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Active Pharmaceutical Ingredient Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Active Pharmaceutical Ingredient Average Price by Players/Suppliers (2013-2018)
2.4 United States Active Pharmaceutical Ingredient Market Competitive Situation and Trends
  2.4.1 United States Active Pharmaceutical Ingredient Market Concentration Rate
  2.4.2 United States Active Pharmaceutical Ingredient Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Active Pharmaceutical Ingredient Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENT SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Active Pharmaceutical Ingredient Sales and Market Share by Region (2013-2018)
3.2 United States Active Pharmaceutical Ingredient Revenue and Market Share by Region (2013-2018)
3.3 United States Active Pharmaceutical Ingredient Price by Region (2013-2018)

4 UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENT SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Active Pharmaceutical Ingredient Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Active Pharmaceutical Ingredient Revenue and Market Share by Type (2013-2018)
4.3 United States Active Pharmaceutical Ingredient Price by Type (2013-2018)
4.4 United States Active Pharmaceutical Ingredient Sales Growth Rate by Type (2013-2018)

5 UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENT SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Active Pharmaceutical Ingredient Sales and Market Share by Application (2013-2018)
5.2 United States Active Pharmaceutical Ingredient Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENT PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Teva
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Active Pharmaceutical Ingredient Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Teva Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Novartis
  6.2.2 Active Pharmaceutical Ingredient Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Novartis Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Pfizer
  6.3.2 Active Pharmaceutical Ingredient Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Pfizer Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Johnson & Johnson
  6.4.2 Active Pharmaceutical Ingredient Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Johnson & Johnson Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Mylan
  6.5.2 Active Pharmaceutical Ingredient Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Mylan Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 North China Pharmaceutical Group
  6.6.2 Active Pharmaceutical Ingredient Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 North China Pharmaceutical Group Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Dr. Reddy’s Laboratories
  6.7.2 Active Pharmaceutical Ingredient Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Roche
  6.8.2 Active Pharmaceutical Ingredient Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Roche Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Aurobindo pharma
  6.9.2 Active Pharmaceutical Ingredient Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Aurobindo pharma Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Sun Pharmaceutical Industries
  6.10.2 Active Pharmaceutical Ingredient Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview
6.11 Boehringer Ingelheim GmbH
6.12 Bayer
6.13 BASF
6.14 DSM
6.15 Zhejiang Medicine
6.16 Biocon
6.17 Johnson Matthey
6.18 Hisun Pharmacy
6.19 Cambrex
6.20 Shandong Xinhua Pharmaceutical
6.21 Lonza group
6.22 Huahai Pharmaceutical
6.23 Haerbin Pharmaceutical Group
6.24 Cipla
6.25 Tian Yao
6.26 Lupin
6.27 North East Pharmaceutical
6.28 Albemarle
6.29 Shandong Lukang Pharmaceutical
6.30 Jiangsu　Hengrui Medicine

7 ACTIVE PHARMACEUTICAL INGREDIENT MANUFACTURING COST ANALYSIS

7.1 Active Pharmaceutical Ingredient Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Active Pharmaceutical Ingredient

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Active Pharmaceutical Ingredient Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Active Pharmaceutical Ingredient Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Active Pharmaceutical Ingredient Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Active Pharmaceutical Ingredient Sales Volume Forecast by Type (2018-2025)
11.3 United States Active Pharmaceutical Ingredient Sales Volume Forecast by Application (2018-2025)
11.4 United States Active Pharmaceutical Ingredient Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Active Pharmaceutical Ingredient
Figure United States Active Pharmaceutical Ingredient Market Size (K MT) by Type (2013-2025)
Figure United States Active Pharmaceutical Ingredient Sales Volume Market Share by Type (Product Category) in 2017
Figure Synthetic API Product Picture
Figure Biotech API Product Picture
Figure Other Product Picture
Figure United States Active Pharmaceutical Ingredient Market Size (K MT) by Application (2013-2025)
Figure United States Sales Market Share of Active Pharmaceutical Ingredient by Application in 2017
Figure Chemical Examples
Table Key Downstream Customer in Chemical
Figure Deodorant Examples
Table Key Downstream Customer in Deodorant
Figure Dailylife Examples
Table Key Downstream Customer in Dailylife
Figure United States Active Pharmaceutical Ingredient Market Size (Million USD) by Region (2013-2025)
Figure The West Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2013-2025)
Figure United States Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Active Pharmaceutical Ingredient Market Major Players Product Sales Volume (K MT) (2013-2018)
Table United States Active Pharmaceutical Ingredient Sales (K MT) of Key Players/Suppliers (2013-2018)
Table United States Active Pharmaceutical Ingredient Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Active Pharmaceutical Ingredient Sales Share by Players/Suppliers
Figure 2017 United States Active Pharmaceutical Ingredient Sales Share by Players/Suppliers
Figure United States Active Pharmaceutical Ingredient Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Active Pharmaceutical Ingredient Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Active Pharmaceutical Ingredient Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Active Pharmaceutical Ingredient Revenue Share by Players/Suppliers
Figure 2017 United States Active Pharmaceutical Ingredient Revenue Share by Players/Suppliers
Table United States Market Active Pharmaceutical Ingredient Average Price (USD/MT) of Key Players/Suppliers (2013-2018)
Figure United States Market Active Pharmaceutical Ingredient Average Price (USD/MT) of Key Players/Suppliers in 2017
Figure United States Active Pharmaceutical Ingredient Market Share of Top 3 Players/Suppliers
Figure United States Active Pharmaceutical Ingredient Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Active Pharmaceutical Ingredient Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Active Pharmaceutical Ingredient Product Category
Table United States Active Pharmaceutical Ingredient Sales (K MT) by Region (2013-2018)
Table United States Active Pharmaceutical Ingredient Sales Share by Region (2013-2018)
Figure United States Active Pharmaceutical Ingredient Sales Share by Region (2013-2018)
Figure United States Active Pharmaceutical Ingredient Sales Market Share by Region in 2017
Table United States Active Pharmaceutical Ingredient Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Active Pharmaceutical Ingredient Revenue Share by Region (2013-2018)
Figure United States Active Pharmaceutical Ingredient Revenue Market Share by Region (2013-2018)
Figure United States Active Pharmaceutical Ingredient Revenue Market Share by Region in 2017
Table United States Active Pharmaceutical Ingredient Price (USD/MT) by Region (2013-2018)
Table United States Active Pharmaceutical Ingredient Sales (K MT) by Type (2013-2018)
Table United States Active Pharmaceutical Ingredient Sales Share by Type (2013-2018)
Figure United States Active Pharmaceutical Ingredient Sales Share by Type (2013-2018)
Figure United States Active Pharmaceutical Ingredient Sales Market Share by Type in 2017
Table United States Active Pharmaceutical Ingredient Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Active Pharmaceutical Ingredient Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Active Pharmaceutical Ingredient by Type (2013-2018)
Figure Revenue Market Share of Active Pharmaceutical Ingredient by Type in 2017
Table United States Active Pharmaceutical Ingredient Price (USD/MT) by Types (2013-2018)
Figure United States Active Pharmaceutical Ingredient Sales Growth Rate by Type (2013-2018)
Table United States Active Pharmaceutical Ingredient Sales (K MT) by Application (2013-2018)
Table United States Active Pharmaceutical Ingredient Sales Market Share by Application (2013-2018)
Figure United States Active Pharmaceutical Ingredient Sales Market Share by Application (2013-2018)
Figure United States Active Pharmaceutical Ingredient Sales Market Share by Application in 2017
Table United States Active Pharmaceutical Ingredient Sales Growth Rate by Application (2013-2018)
Figure United States Active Pharmaceutical Ingredient Sales Growth Rate by Application (2013-2018)
Table Teva Basic Information List
Table Teva Active Pharmaceutical Ingredient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Teva Active Pharmaceutical Ingredient Sales Growth Rate (2013-2018)
Figure Teva Active Pharmaceutical Ingredient Sales Market Share in United States (2013-2018)
Figure Teva Active Pharmaceutical Ingredient Revenue Market Share in United States (2013-2018)
Table Novartis Basic Information List
Table Novartis Active Pharmaceutical Ingredient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Novartis Active Pharmaceutical Ingredient Sales Growth Rate (2013-2018)
Figure Novartis Active Pharmaceutical Ingredient Sales Market Share in United States (2013-2018)
Figure Novartis Active Pharmaceutical Ingredient Revenue Market Share in United States (2013-2018)
Table Pfizer Basic Information List
Table Pfizer Active Pharmaceutical Ingredient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Pfizer Active Pharmaceutical Ingredient Sales Growth Rate (2013-2018)
Figure Pfizer Active Pharmaceutical Ingredient Sales Market Share in United States (2013-2018)
Figure Pfizer Active Pharmaceutical Ingredient Revenue Market Share in United States (2013-2018)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Active Pharmaceutical Ingredient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Johnson & Johnson Active Pharmaceutical Ingredient Sales Growth Rate (2013-2018)
Figure Johnson & Johnson Active Pharmaceutical Ingredient Sales Market Share in United States (2013-2018)
Figure Johnson & Johnson Active Pharmaceutical Ingredient Revenue Market Share in United States (2013-2018)
Table Mylan Basic Information List
Table Mylan Active Pharmaceutical Ingredient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Mylan Active Pharmaceutical Ingredient Sales Growth Rate (2013-2018)
Figure Mylan Active Pharmaceutical Ingredient Sales Market Share in United States (2013-2018)
Figure Mylan Active Pharmaceutical Ingredient Revenue Market Share in United States (2013-2018)
Table North China Pharmaceutical Group Basic Information List
Table North China Pharmaceutical Group Active Pharmaceutical Ingredient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure North China Pharmaceutical Group Active Pharmaceutical Ingredient Sales Growth Rate (2013-2018)
Figure North China Pharmaceutical Group Active Pharmaceutical Ingredient Sales Market Share in United States (2013-2018)
Figure North China Pharmaceutical Group Active Pharmaceutical Ingredient Revenue Market Share in United States (2013-2018)
Table Dr. Reddy’s Laboratories Basic Information List
Table Dr. Reddy’s Laboratories Active Pharmaceutical Ingredient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Dr. Reddy’s Laboratories Active Pharmaceutical Ingredient Sales Growth Rate (2013-2018)
Figure Dr. Reddy’s Laboratories Active Pharmaceutical Ingredient Sales Market Share in United States (2013-2018)
Figure Dr. Reddy’s Laboratories Active Pharmaceutical Ingredient Revenue Market Share in United States (2013-2018)
Table Roche Basic Information List
Table Roche Active Pharmaceutical Ingredient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Roche Active Pharmaceutical Ingredient Sales Growth Rate (2013-2018)
Figure Roche Active Pharmaceutical Ingredient Sales Market Share in United States (2013-2018)
Figure Roche Active Pharmaceutical Ingredient Revenue Market Share in United States (2013-2018)
Table Aurobindo pharma Basic Information List
Table Aurobindo pharma Active Pharmaceutical Ingredient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Aurobindo pharma Active Pharmaceutical Ingredient Sales Growth Rate (2013-2018)
Figure Aurobindo pharma Active Pharmaceutical Ingredient Sales Market Share in United States (2013-2018)
Figure Aurobindo pharma Active Pharmaceutical Ingredient Revenue Market Share in United States (2013-2018)
Table Sun Pharmaceutical Industries Basic Information List
Table Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Sales Growth Rate (2013-2018)
Figure Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Sales Market Share in United States (2013-2018)
Figure Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Revenue Market Share in United States (2013-2018)
Table Boehringer Ingelheim GmbH Basic Information List
Table Bayer Basic Information List
Table BASF Basic Information List
Table DSM Basic Information List
Table Zhejiang Medicine Basic Information List
Table Biocon Basic Information List
Table Johnson Matthey Basic Information List
Table Hisun Pharmacy Basic Information List
Table Cambrex Basic Information List
Table Shandong Xinhua Pharmaceutical Basic Information List
Table Lonza group Basic Information List
Table Huahai Pharmaceutical Basic Information List
Table Haerbin Pharmaceutical Group Basic Information List
Table Cipla Basic Information List
Table Tian Yao Basic Information List
Table Lupin Basic Information List
Table North East Pharmaceutical Basic Information List
Table Albemarle Basic Information List
Table Shandong Lukang Pharmaceutical Basic Information List
Table Jiangsu　Hengrui Medicine Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Active Pharmaceutical Ingredient
Figure Manufacturing Process Analysis of Active Pharmaceutical Ingredient
Figure Active Pharmaceutical Ingredient Industrial Chain Analysis
Table Raw Materials Sources of Active Pharmaceutical Ingredient Major Players/Suppliers in 2017
Table Major Buyers of Active Pharmaceutical Ingredient
Table Distributors/Traders List
Figure United States Active Pharmaceutical Ingredient Sales Volume (K MT) and Growth Rate Forecast (2018-2025)
Figure United States Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Active Pharmaceutical Ingredient Price (USD/MT) Trend Forecast (2018-2025)
Table United States Active Pharmaceutical Ingredient Sales Volume (K MT) Forecast by Type (2018-2025)
Figure United States Active Pharmaceutical Ingredient Sales Volume (K MT) Forecast by Type (2018-2025)
Figure United States Active Pharmaceutical Ingredient Sales Volume (K MT) Forecast by Type in 2025
Table United States Active Pharmaceutical Ingredient Sales Volume (K MT) Forecast by Application (2018-2025)
Figure United States Active Pharmaceutical Ingredient Sales Volume (K MT) Forecast by Application (2018-2025)
Figure United States Active Pharmaceutical Ingredient Sales Volume (K MT) Forecast by Application in 2025
Table United States Active Pharmaceutical Ingredient Sales Volume (K MT) Forecast by Region (2018-2025)
Table United States Active Pharmaceutical Ingredient Sales Volume Share Forecast by Region (2018-2025)
Figure United States Active Pharmaceutical Ingredient Sales Volume Share Forecast by Region (2018-2025)
Figure United States Active Pharmaceutical Ingredient Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources